These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32143897)

  • 41. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention.
    Yang J; Tang YD; Zheng Y; Li C; Zhou Q; Gao J; Meng X; Zhang K; Wang W; Shao C
    Front Endocrinol (Lausanne); 2021; 12():710240. PubMed ID: 34489866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
    BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
    Winzap P; Davies A; Klingenberg R; Obeid S; Roffi M; Mach F; Räber L; Windecker S; Templin C; Nietlispach F; Nanchen D; Gencer B; Muller O; Matter CM; von Eckardstein A; Lüscher TF
    Cardiovasc Diabetol; 2019 Oct; 18(1):142. PubMed ID: 31672144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of free fatty acids on prognosis in coronary artery disease patients under different glucose metabolism status.
    Jin JL; Cao YX; Liu HH; Zhang HW; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Sun J; Dong Q; Li JJ
    Cardiovasc Diabetol; 2019 Oct; 18(1):134. PubMed ID: 31610783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients.
    Scicali R; Giral P; Gallo A; Di Pino A; Rabuazzo AM; Purrello F; Cluzel P; Redheuil A; Bruckert E; Rosenbaum D
    Atherosclerosis; 2016 Dec; 255():102-108. PubMed ID: 27870948
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective study of the impact of diabetes mellitus newly diagnosed by glycated hemoglobin on outcomes in patients undergoing percutaneous coronary intervention.
    Tailakh MA; Friger M; Zahger D; Sidi A; Mazor-Dray E; Novack V
    Eur J Intern Med; 2017 Jan; 37():69-74. PubMed ID: 27665509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.
    Cosson E; Hamo-Tchatchouang E; Banu I; Nguyen MT; Chiheb S; Ba H; Valensi P
    Diabetes Metab; 2010 Sep; 36(4):312-8. PubMed ID: 20627649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes.
    Cao YX; Zhang HW; Jin JL; Liu HH; Zhang Y; Gao Y; Guo YL; Wu NQ; Hua Q; Li YF; Li XL; Xu RX; Cui CJ; Liu G; Dong Q; Sun J; Zhu CG; Li JJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):104. PubMed ID: 32631321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utility of Glycated Hemoglobin for Assessment of Glucose Metabolism in Patients With ST-Segment Elevation Myocardial Infarction.
    Aggarwal B; Shah GK; Randhawa M; Ellis SG; Lincoff AM; Menon V
    Am J Cardiol; 2016 Mar; 117(5):749-53. PubMed ID: 26768673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014.
    Ali MK; Bullard KM; Saydah S; Imperatore G; Gregg EW
    Lancet Diabetes Endocrinol; 2018 May; 6(5):392-403. PubMed ID: 29500121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of prediabetes on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries.
    Gao S; Ma W; Huang S; Lin X; Yu M
    Diabetol Metab Syndr; 2021 Sep; 13(1):103. PubMed ID: 34560905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence, Predictors, and Clinical Outcomes of New-Onset Diabetes Mellitus after Percutaneous Coronary Intervention with Drug-Eluting Stent.
    Chun KH; Im E; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    J Korean Med Sci; 2017 Oct; 32(10):1603-1609. PubMed ID: 28875603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of baseline thrombocytopenia on the long-term outcome of patients undergoing elective percutaneous coronary intervention: An analysis of 9,897 consecutive patients.
    Liu S; Song C; Zhao Y; Guan C; Zhu C; Feng L; Xu B; Dou K
    Catheter Cardiovasc Interv; 2019 Feb; 93(S1):764-771. PubMed ID: 30585392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria.
    Rosella LC; Lebenbaum M; Fitzpatrick T; Zuk A; Booth GL
    Diabetes Care; 2015 Jul; 38(7):1299-305. PubMed ID: 25852207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical impact of diabetes mellitus on 2-year clinical outcomes following PCI with second-generation drug-eluting stents; Landmark analysis findings from patient registry: Pooled analysis of the Korean multicenter drug-eluting stent registry.
    Lee CH; Choi SW; Jun SW; Hwang J; Kim IC; Cho YK; Park HS; Yoon HJ; Kim H; Nam CW; Han S; Kim KB; Hur SH
    PLoS One; 2020; 15(6):e0234362. PubMed ID: 32520973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention.
    Balakrishnan R; Berger JS; Tully L; Vani A; Shah B; Burdowski J; Fisher E; Schwartzbard A; Sedlis S; Weintraub H; Underberg JA; Danoff A; Slater JA; Gianos E
    Diabetes Metab Res Rev; 2015 Sep; 31(6):603-9. PubMed ID: 25728823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study.
    Parizadeh D; Rahimian N; Akbarpour S; Azizi F; Hadaegh F
    Eur J Prev Cardiol; 2019 Jul; 26(10):1080-1091. PubMed ID: 30862232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.